Bavarian Nordic upgrades guidance for third time in three weeks
For the third time in three weeks, Bavarian Nordic has increased its stated financial expectations for the year. This comes after a deal was secured with the US government concerning the firm’s monkeypox vaccine.
by christopher due karlsson, translated by catherine brett
Bavarian Nordic has entered into an agreement with the US government concerning the firm’s monkeypox vaccine, and in connection with this, has upgraded its financial guidance again.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
.jpg&w=384&q=75)
